Low Incidence of Oral Squamous Cell Carcinoma in Patients With Oral Lichen Planus on Sustained Anti-Inflammatory Therapy: A Single-Centre Retrospective Study of 273 Patients
Journal of Cutaneous Medicine and Surgery · 2025
DOI: 10.1177/12034754251324945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Medicine and Surgery, 2025. Verfasst von Jose W Ricardo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Weill Cornell Medicine, New York, NY, USA. Hauptthemen laut MEDLINE: Lichen Planus, Oral, Carcinoma, Squamous Cell, Mouth Neoplasms, Anti-Inflammatory Agents. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Background
Oral lichen planus (OLP), a chronic inflammatory disease, can progress to oral squamous cell carcinoma (OSCC). The malignant transformation rate may be lower in OLP patients receiving anti-inflammatory therapy.
Objective
To describe cases of malignant transformation among OLP patients on topical/systemic anti-inflammatory therapy.
Methods
The medical records of 273 patients with OLP at an academic institution were retrospectively reviewed. Patients with epithelial dysplasia at OLP diagnosis were excluded. Biopsy-confirmed OSCC cases diagnosed ≥6 months after the initial visit were included. Chi-square and t -tests compared categorical and numerical variables, respectively.
Results
The mean age at OLP diagnosis was 63 years (standard deviation [SD]: 12.2, range: 19-92); 79.9% were women and 89.4% were White. Most patients had erosive OLP (EOLP) (61.9%). 16.5% had concurrent genital LP and 10.6% had cutaneous LP. Tacrolimus swish-and-spit was the most frequently prescribed treatment (100%), followed by 10 mg clotrimazole troches (89.4%) and topical corticosteroids (85%). The median duration of clinical follow-up was 2.9 years (interquartile range: 1-5.5). Three (1.1%) patients developed OSCC on average 6.3 years post-OLP diagnosis, all with EOLP. OSCC most frequently affected the tongue (66.7%), followed by the gingiva (33.3%). Out of 3 tumours, one was stage II, one was stage III, and one was stage IV. OLP patients with vs. without OSCC were more often male ( P = .04) and more frequently experienced dysphagia ( P < .001).
Conclusion
OSCC incidence was low in OLP patients on sustained anti-inflammatory therapy, occurring exclusively in those with EOLP. Males and patients with dysphagia more often developed OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Weill Cornell Medicine, New York, NY, USA.
- Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
ORCID-Profile: Jose W Ricardo, Christina Kontzias, Yu Wang
Zitieren
APA
Ricardo, J. W., Oscherwitz, M. E., Read, M. H., Wiater, A. H., Kontzias, C., Cleland, J. B., Wang, Y., & Jorizzo, J. (2025). Low Incidence of Oral Squamous Cell Carcinoma in Patients With Oral Lichen Planus on Sustained Anti-Inflammatory Therapy: A Single-Centre Retrospective Study of 273 Patients. Journal of Cutaneous Medicine and Surgery. https://doi.org/10.1177/12034754251324945
Vancouver
Ricardo JW, Oscherwitz ME, Read MH, Wiater AH, Kontzias C, Cleland JB, et al. Low Incidence of Oral Squamous Cell Carcinoma in Patients With Oral Lichen Planus on Sustained Anti-Inflammatory Therapy: A Single-Centre Retrospective Study of 273 Patients. Journal of Cutaneous Medicine and Surgery. 2025. doi:10.1177/12034754251324945
BibTeX
@article{Ricardo2025,
author = {Ricardo, Jose W and Oscherwitz, Max E and Read, Madison H and Wiater, Angelina H and Kontzias, Christina and Cleland, Jane B and Wang, Yu and Jorizzo, Joseph},
title = {Low Incidence of Oral Squamous Cell Carcinoma in Patients With Oral Lichen Planus on Sustained Anti-Inflammatory Therapy: A Single-Centre Retrospective Study of 273 Patients},
journal = {Journal of Cutaneous Medicine and Surgery},
year = {2025},
doi = {10.1177/12034754251324945}
}
EUVIMED